abstract
untuk sel Vero adalah 3,36 µg / ml; demikian nilai SI untuk Cobalt (II)-Morin adalah 1.09. Hasil penelitian ini menunjukkan bahwa Cobalt (II) -Morin menunjukkan aktivitas penghambatan serotipe 2 anti-dengue dan memiliki sifat beracun pada sel Vero. Studi lebih lanjut tidak diperlukan sebelum Co (II)-Morin dapat diterapkan dalam pengobatan infeksi DENV-2.
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Dengue virus (DENV) serotypes DENV-1-DENV-4 are enveloped viruses that belong to the genus Flavivirus of the Flaviviridae; it is widespread in the tropical and subtropical areas globally. The World Health Organization reported that the incidence of dengue increased 30-fold in the last five decades, and it is estimated that about 390 million people are infected with DENV worldwide. 1 Many efforts have been made to prevent and treat DENV infection, and clinical trials of a number of vaccines are currently underway. 2 Antiviral activity against DENV is an important alternative for the characterization and development of drugs. Complementary to vaccine, inhibitors of any natural step of the virus's replicative cycle have the potential for the treatment of DENV infection and indeed compounds such as inhibitors of RNA replication are already tested as such. 3 However, there is no drug commercially available yet with antiviral activity for DENV. 4 M o r i n o r 2 -( 2 , 4 -d i h y d r o x y p h e n y l ) -3 , 5 , 7 -trihydroxychromen-4-one is a flavonoid that exhibits various biological activities, such as anti-Bacillus cereus and anti-Salmonella enteritidis, 5 antioxidant, 6 antiinflammatory, 7 and antiviral for equid herpesvirus 1. 8 However, the antiviral activity for DENV has not been reported yet.
Metals have been used in the treatment and prevention of diseases of humans since ancient times. Already in 2500 BC in China elemental gold was in use as therapy for certain diseases, so-called chrysotherapy. 9 Gold and the more recently developed nano-gold have already had a large impact on medicine, especially in HIV therapy and cancer treatment. 10 Metal-organic compounds were reported to exhibit fungicidal, 11 bactericidal, [11] [12] [13] [14] and antiviral 13, 15 activities.
In a previous study, ribavirin was shown to exert its toxicity by inhibiting the intracellular energy metabolism and oxidative membrane damage, leading to accelerated extravascular hemolysis by the reticuloendothelial system. Although its inhibitory activity was not significant, at high concentration it was more toxic to replicating cells than to stationary cell monolayers of Vero cells. 16 Currently, there are no published data on the possible anti-DENV activities of cobalt compounds. In the present study, the inhibitory activity of Cobalt(II)-Morin complex against the replication of DENV-2 in cell culture was investigated.
material and method
chemicals and Media
The chemical reagents used in this research were the Cobalt(II)-Morin complex compound, dimethyl sulfoxide (Merck 99.98%, Germany), Minimum Essential Eagle Medium (sigma-Aldrich, Germany), dengue virus serotype 2 surabaya Isolate (KT012513), Vero cell (African green monkey kidney), CellTiter96® Non-Radioactive Proliferation reagent (Promega, UsA), and DENV antibody (4G2) for enzyme-linked immunosorbent assay (ELIsA).
Antiviral Activity Assay
Confluent monolayers of Vero cells were prepared on a 96-well plate (1 × 10 6 cells/10 ml) and counted using a hemocytometer, and the titer of DENV-2 (2 × 10 4 FFU/well) was expressed in Foci-Forming Units (FFU) after incubating at 37°C for 2 days. The 50% inhibitory concentration (IC 50 ) was calculated as follows: IC 50 = (NC − AC) × 100/NC, where NC is the mean of the number of negative controls and AC is the absorbance of the compound tested. The inhibition of DENV-2 replication by each compound was further investigated by using quantitative ELIsA.
cytotoxicity Assay
A cytotoxicity assay was performed using CellTiter96® Non-Radioactive Proliferation reagent. The CellTiter96® Assay is a modification of the MTT assay method described by Mosmann. 17 The assay is very sensitive: it can detect 1,000 cells/well of a 96-well plate reader. Vero cells (1 × 10 5 cells/ml), 500 µl of serial dilution compound, and a total of 100 µl of Cell Proliferation Reagent was added to each well of a 96-well plate and incubated under 5% CO 2 at 37°C for 1-4 hours. The plate was read at 570 nm using an iMark TM Microplate Absorbance Reader.
results and discussion
Antiviral Activity of cobalt(II)-Morin
A significant inhibitory activity to that of the complex Cobalt(II)-Morin was displayed against the tested pathogenic DENV-2 virus in Vero cells. In the inhibitory activity test, we studied the ability of the compound to produce a direct virus-inactivating effect. The IC 50 value was determined from the concentration-response curve ( Figure 1) ; the IC 50 value was 3.08 µg/ml, R 2 was 0.9404, and the value of the selectivity index (sI) was 1.09. The sI of the antiviral compound appeared to be moderately influenced by the strain of DENV tested. 18 The emergence of arboviruses worldwide raises the necessity of developing a new strategy for the treatment of the diseases they cause. several approaches have been demonstrated for the treatment of DENV-2 in which Cobalt(II)-Morin at concentrations of micrograms per milliliter promote inactivation. The antiviral activity of natural and synthetic Morin has been described for distinct viruses. 8, 19 In members of the Flaviviridae family, the activity of Morin has been described for the replication system of Canine distemper virus). Here, the IC 50 value of Morin is 40.52 ± 1.69 µg/ml for a 1-hour incubation. Investigation of Morin's structure showed that the compound is able to inhibit the adsorption and penetration stages. 19 In HepG2 cells, the protection conferred by heme and Co(II)-protoporphyrin IX seems to be the result of decreased DENV-2 replication upon treatment. The IC 50 value was reported to be 3.912 ± 1.4 µmol/l. Treatment of THP-1 cells with Co(II)-protoporphyrin IX, after infection at a low multiplicity of infection showed similar results regarding cell viability and DENV replication after 72 hours post inoculation. This in vitro studies indicate a potential therapeutic use porphyrins in the treatment of flavivirus infection. 4 Figure 2 shows the structure of Morin. Morin has hydroxyl groups at C-2′ and C-4′ (meta position). The activity of Morin might be related to the position of the hydroxyl groups at C-2′, which might prevent its biological effects on virus. However, the specific mechanism of Co(II)-Morin is still unclear.
A significant inhibitory activity to that of the complex Cobalt(II) Figure 1) ; the IC 50 value was 3.08 µg/ml, R 2 was 0.9404, and the value of the selectivity index (SI) was 1.09. The SI of the antiviral compound appeared to be moderately influenced by the strain of DENV tested. Cobalt(II) is stable in water by coordinating to ligands or chelators and is more stable than Co(III). 13 When compared with a previous study, it has been revealed that Co(II) is more toxic than Cu(II) with a CC 50 value of 5.03 µg/ml. 18 Copper(II) was found to be nontoxic to human erythrocyte cells even at a concentration of 500 µg/ml. The cytotoxic activity of Co(II)-Morin was investigated. This compound was tested against Vero cells at different concentrations to determine the CC 50 value using CellTiter96® Non-Radioactive Proliferation reagent. The CC 50 value was found to increase with an increasing concentration of the test compound, as shown in Figure  3 . The CC 50 of Cobalt(II)-Morin for Vero cells was 3.36 µg/ml, with an R 2 value of 0.9493. In this study, we have examined the relationship between the concentration of Vero cells in the culture medium and the cytotoxic potency of Cobalt(II)-Morin.
Cobalt(II) is stable in water by coordinating to ligands or chelators and is more stable than Co(III). 13 When compared with a previous study, it has been revealed that Co(II) is more toxic than Cu(II) with a CC 50 value of 5.03 µg/ml. 18 Copper(II) was found to be nontoxic to human erythrocyte cells even at a concentration of 500 µg/ml. 20 
conclusion
Further studies are not required before Co(II)-Morin can be applied in the treatment of DENV-2 infections. This study did not show the potential of the Co(II)-Morin complex as a candidate for antiviral agent against DENV-2 because it was shown to be toxic to Vero cells. 
